These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1150 related items for PubMed ID: 17477366

  • 21. Antagonistic interaction between bicalutamide (Casodex) and radiation in androgen-positive prostate cancer LNCaP cells.
    Quéro L, Giocanti N, Hennequin C, Favaudon V.
    Prostate; 2010 Mar 01; 70(4):401-11. PubMed ID: 19902473
    [Abstract] [Full Text] [Related]

  • 22. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
    Sadar MD, Gleave ME.
    Cancer Res; 2000 Oct 15; 60(20):5825-31. PubMed ID: 11059779
    [Abstract] [Full Text] [Related]

  • 23. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y, Mizokami A, Miwa S, Koshida K, Namiki M.
    Int J Urol; 2007 Mar 15; 14(3):233-9. PubMed ID: 17430262
    [Abstract] [Full Text] [Related]

  • 24. Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I.
    Catrina SB, Botusan IR, Rantanen A, Catrina AI, Pyakurel P, Savu O, Axelson M, Biberfeld P, Poellinger L, Brismar K.
    Clin Cancer Res; 2006 Aug 01; 12(15):4506-14. PubMed ID: 16899596
    [Abstract] [Full Text] [Related]

  • 25. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC, Astapova I, Hollenberg AN, Balk SP.
    Cancer Res; 2007 Sep 01; 67(17):8388-95. PubMed ID: 17804755
    [Abstract] [Full Text] [Related]

  • 26. Hypoxia-inducible factor-1 in human breast and prostate cancer.
    Kimbro KS, Simons JW.
    Endocr Relat Cancer; 2006 Sep 01; 13(3):739-49. PubMed ID: 16954428
    [Abstract] [Full Text] [Related]

  • 27. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
    Wang LG, Liu XM, Kreis W, Budman DR.
    Biochem Biophys Res Commun; 1999 May 27; 259(1):21-8. PubMed ID: 10334909
    [Abstract] [Full Text] [Related]

  • 28. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression.
    Sato F, Bhawal UK, Kawamoto T, Fujimoto K, Imaizumi T, Imanaka T, Kondo J, Koyanagi S, Noshiro M, Yoshida H, Kusumi T, Kato Y, Kijima H.
    Genes Cells; 2008 Feb 27; 13(2):131-44. PubMed ID: 18233956
    [Abstract] [Full Text] [Related]

  • 29. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
    Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM, Weigel NL.
    Cancer Res; 2006 Nov 01; 66(21):10594-602. PubMed ID: 17079484
    [Abstract] [Full Text] [Related]

  • 30. Effect of the hsp90 inhibitor geldanamycin on androgen response of prostate cancer under hypoxic conditions.
    Suzuki Y, Kondo Y, Hara S, Kimata R, Nishimura T.
    Int J Urol; 2010 Mar 01; 17(3):281-5. PubMed ID: 20409220
    [Abstract] [Full Text] [Related]

  • 31. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
    Paliouras M, Diamandis EP.
    Biol Chem; 2008 Jun 01; 389(6):773-80. PubMed ID: 18627304
    [Abstract] [Full Text] [Related]

  • 32. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT, Le H, McFann KK, Blackman MR.
    Am J Physiol Endocrinol Metab; 2005 Mar 01; 288(3):E573-84. PubMed ID: 15536203
    [Abstract] [Full Text] [Related]

  • 33. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ, Robson CN, Neal DE, Leung HY.
    Oncogene; 2002 Aug 01; 21(33):5069-80. PubMed ID: 12140757
    [Abstract] [Full Text] [Related]

  • 34. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells.
    Ghafar MA, Anastasiadis AG, Chen MW, Burchardt M, Olsson LE, Xie H, Benson MC, Buttyan R.
    Prostate; 2003 Jan 01; 54(1):58-67. PubMed ID: 12481256
    [Abstract] [Full Text] [Related]

  • 35. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G.
    Cancer Res; 1997 Mar 15; 57(6):1086-90. PubMed ID: 9067276
    [Abstract] [Full Text] [Related]

  • 36. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate.
    Kinoshita M, Nakagawa T, Shimizu A, Katsuoka Y.
    Int J Urol; 2005 Apr 15; 12(4):390-7. PubMed ID: 15948728
    [Abstract] [Full Text] [Related]

  • 37. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer.
    Boddy JL, Fox SB, Han C, Campo L, Turley H, Kanga S, Malone PR, Harris AL.
    Clin Cancer Res; 2005 Nov 01; 11(21):7658-63. PubMed ID: 16278385
    [Abstract] [Full Text] [Related]

  • 38. Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells.
    Collado B, Sánchez-Chapado M, Prieto JC, Carmena MJ.
    Mol Cell Endocrinol; 2006 Apr 25; 249(1-2):116-22. PubMed ID: 16563610
    [Abstract] [Full Text] [Related]

  • 39. Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10.
    Ishikura N, Kawata H, Nishimoto A, Nakamura R, Ishii N, Aoki Y.
    Prostate; 2010 Apr 01; 70(5):457-66. PubMed ID: 19902465
    [Abstract] [Full Text] [Related]

  • 40. Hypoxia-inducible factor 1alpha and 1beta proteins share common signaling pathways in human prostate cancer cells.
    Zhong H, Hanrahan C, van der Poel H, Simons JW.
    Biochem Biophys Res Commun; 2001 Jun 08; 284(2):352-6. PubMed ID: 11394885
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.